Humanigen Inc (fka HGENQ)

[Moderna]

Recommendators to credit holders or creditors and shareholders who still own the patent to OBJECT the bankutpcy filing and selling of assets. Suspend creditor claims and lawsuits and solicit additional equity investors via share dilution and keep ownership of the asset or drug patent. as that is the only asset the company has. if its sold in auction for 2 million as stalking bid by a company owned by the CEO, credit holders will receive nothing nor will shareholders who previously own the drug patent. As of now the patent is under clinical state and if approved it's worth 1 billion. The stalking bid is facade to complete and expedite the chapter 11 filing to wipe out the 160 million raised during the equity offer.